Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Oxytocin and Phentolamine

supplement:

Oxytocin

Research Papers that Mention the Interaction

Furthermore, pretreatment with phentolamine significantly diminished systemic OT release in response to icv Ang II.
Regulatory Peptides  •  2003  |  View Paper
In addition, a co‐infusion of oxytocin with phentolamine abolishes recognition responses (experiment 3).
The European journal of neuroscience  •  2000  |  View Paper
Furthermore, the increases in OT concentration in dialysates and plasma were prevented by simultaneous administration of chlorpheniramine (an H1 receptor antagonist) or ranitidine (an H2 receptor antagonist) as well as by the adrenergic antagonist phentolamine.
Endocrinology  •  1999  |  View Paper
Stimulation of peripheral alpha-adrenergic receptors with phenylephrine did not affect either basal or suckling-induced OT release, but blockade of alpha-adrenergic receptors with phentolamine also completely prevented the release of OT by suckling.
Brain Research  •  1988  |  View Paper
Oxytocin produced an acute decrease in this threshold dose on phentolamine or methysergide, but was inhibited by papaverine, dibutyryl cAMP, salbutamol and verapamil.
Nihon yakurigaku zasshi. Folia pharmacologica Japonica  •  1981  |  View Paper
In intact rats, alpha adrenergic receptor blocking agents, phenoxybenzamine (PBZ) and phentolamine potentiated the pressor response to oxytocin and vasopressin (VP).
In the presence of PBZ or phentolamine blockade, the dose-response curves of oxytocin and VP were shifted to the left, resulting in an apparent doubling of the pressor potency of the neurohypophysial peptides.
The Journal of pharmacology and experimental therapeutics  •  1977  |  View Paper